Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | ATM |
Variant | V1268fs |
Impact List | frameshift |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | ATM V1268fs results in a change in the amino acid sequence of the Atm protein beginning at aa 1268 of 3056, likely resulting in premature truncation of the functional protein (UniProt.org). V1268fs has not been characterized, however, due to the effects of other truncation mutations downstream of V1268 (PMID: 16603769), is predicted to lead to a loss of Atm protein function. |
Associated Drug Resistance | |
Category Variants Paths |
ATM mutant ATM inact mut ATM V1268fs |
Transcript | NM_000051.4 |
gDNA | chr11:g.(108284281_108284282) |
cDNA | c.(3802_3801) |
Protein | p.V1268fs |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_017017789.2 | chr11:g.(108284281_108284282) | c.(3802_3801) | p.V1268fs | RefSeq | GRCh38/hg38 |
XM_047426975.1 | chr11:g.(108284281_108284282) | c.(3802_3801) | p.V1268fs | RefSeq | GRCh38/hg38 |
NM_001351834.2 | chr11:g.(108284281_108284282) | c.(3802_3801) | p.V1268fs | RefSeq | GRCh38/hg38 |
XM_017017790.3 | chr11:g.(108284281_108284282) | c.(3802_3801) | p.V1268fs | RefSeq | GRCh38/hg38 |
XM_006718843.4 | chr11:g.(108284281_108284282) | c.(3802_3801) | p.V1268fs | RefSeq | GRCh38/hg38 |
XM_017017790.2 | chr11:g.(108284281_108284282) | c.(3802_3801) | p.V1268fs | RefSeq | GRCh38/hg38 |
XM_005271562.5 | chr11:g.(108284281_108284282) | c.(3802_3801) | p.V1268fs | RefSeq | GRCh38/hg38 |
XM_047426976.1 | chr11:g.(108284281_108284282) | c.(3802_3801) | p.V1268fs | RefSeq | GRCh38/hg38 |
XM_011542840.3 | chr11:g.(108284281_108284282) | c.(3802_3801) | p.V1268fs | RefSeq | GRCh38/hg38 |
XM_047426981.1 | chr11:g.(108284281_108284282) | c.(3802_3801) | p.V1268fs | RefSeq | GRCh38/hg38 |
XM_017017791.1 | chr11:g.(108284281_108284282) | c.(3802_3801) | p.V1268fs | RefSeq | GRCh38/hg38 |
XM_011542843.3 | chr11:g.(108284281_108284282) | c.(3802_3801) | p.V1268fs | RefSeq | GRCh38/hg38 |
NM_001351834.1 | chr11:g.(108284281_108284282) | c.(3802_3801) | p.V1268fs | RefSeq | GRCh38/hg38 |
NM_000051.4 | chr11:g.(108284281_108284282) | c.(3802_3801) | p.V1268fs | RefSeq | GRCh38/hg38 |
XM_017017792.2 | chr11:g.(108284281_108284282) | c.(3802_3801) | p.V1268fs | RefSeq | GRCh38/hg38 |
NM_000051.3 | chr11:g.(108284281_108284282) | c.(3802_3801) | p.V1268fs | RefSeq | GRCh38/hg38 |
XM_006718843.5 | chr11:g.(108284281_108284282) | c.(3802_3801) | p.V1268fs | RefSeq | GRCh38/hg38 |
XM_005271562.6 | chr11:g.(108284281_108284282) | c.(3802_3801) | p.V1268fs | RefSeq | GRCh38/hg38 |
XM_011542843.2 | chr11:g.(108284281_108284282) | c.(3802_3801) | p.V1268fs | RefSeq | GRCh38/hg38 |
XM_011542840.4 | chr11:g.(108284281_108284282) | c.(3802_3801) | p.V1268fs | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
ATM V1268fs | appendix cancer | predicted - sensitive | Elimusertib | Case Reports/Case Series | Actionable | In a Phase I trial, Elimusertib (BAY1895344) treatment resulted in a partial response with a 35% decrease in tumor size in a patient with appendix cancer harboring ATM V1268fs, treatment was ongoing at 472 days (PMID: 32988960; NCT03188965). | 32988960 |